NEW YORK – Global law firm Reed Smith today announced that it advised Grace Therapeutics, Inc., a privately held biopharmaceutical company focused on developing drug treatment technologies of rare and orphan diseases, on its merger with Acasti Pharma Inc. (Nasdaq: ACST and TSX-V: ACST), a biopharmaceutical company historically focused on the development and commercialization of prescription drugs using Omega-3 fatty acids.
The Reed Smith team was comprised of partners Jennifer Cheng and Niket Rele, counsel Sue Nieto, and associates Doug Sayranian and Sheran Sharafi.
A copy of the press release issued by Acasti Pharma can be found at globenewswire.com.